title: Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patient.
authors.forename: Nader
authors.initials: N
authors.lastname: Bassilios
authors.forename: Vincent
authors.initials: V
authors.lastname: Launay-Vacher
authors.forename: Abdel-Aziz
authors.initials: AA
authors.lastname: Hamani
authors.forename: Laurent
authors.initials: L
authors.lastname: Masias
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Fau
authors.forename: Gilbert
authors.initials: G
authors.lastname: Deray
mesh_terms: D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D016572:Cyclosporine / Q000008:administration & dosage; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D006435:Renal Dialysis; D017828:Rifabutin / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy
chemical_list: D000904:Antibiotics, Antitubercular; D017828:Rifabutin; D016572:Cyclosporine